JUN and ovarian carcinoma: Phosphorylation of c-JUN was increased rapidly with treatment in TRX-E-009-1 sensitive renal cell carcinoma (RCC) and NSCLC cell lines (Supplementary Fig. S5A), confirming previously published results for TRX-E-002-1 in an ovarian cancer model16.